H Ardon

Summary

Affiliation: Katholieke Universiteit Leuven
Country: Belgium

Publications

  1. ncbi Adjuvant dendritic cell-based tumour vaccination for children with malignant brain tumours
    Hilko Ardon
    Department of Neurosurgery, University Hospital Gasthuisberg, Leuven, Belgium
    Pediatr Blood Cancer 54:519-25. 2010
  2. ncbi Technical advancement in regulatory T cell isolation and characterization using CD127 expression in patients with malignant glioma treated with autologous dendritic cell vaccination
    H Ardon
    Department of Neurosurgery, University Hospital Leuven, Leuven, Belgium
    J Immunol Methods 352:169-73. 2010

Detail Information

Publications2

  1. ncbi Adjuvant dendritic cell-based tumour vaccination for children with malignant brain tumours
    Hilko Ardon
    Department of Neurosurgery, University Hospital Gasthuisberg, Leuven, Belgium
    Pediatr Blood Cancer 54:519-25. 2010
    ..A large experience with dendritic cell (DC)-based vaccination for malignant brain tumours has been gained in adults. Here we focus on the results obtained in children with relapsed malignant brain tumours...
  2. ncbi Technical advancement in regulatory T cell isolation and characterization using CD127 expression in patients with malignant glioma treated with autologous dendritic cell vaccination
    H Ardon
    Department of Neurosurgery, University Hospital Leuven, Leuven, Belgium
    J Immunol Methods 352:169-73. 2010
    ..We conclude that CD127 staining is a fast, well-suited and reproducible Treg monitoring tool in HGG patients treated with immunotherapy...